Synthesis of Chromen[4,3-b]pyrrolidines
were computed with the PCM method using toluene as solvent.[45]
All the stationary points were characterized by harmonic analysis.
Reactants, intermediates and products showed positive definite
Hessians. Transition structures (TSs) showed one and only one
imaginary frequency associated with nuclear motion along the
chemical transformation under study. Free energies at 298.15 and
460.15 K were calculated by including the corresponding thermal
corrections to Gibbs free energies (TCGE). Figures including opti-
mized structures were made with Maestro[46] and CYL-view pro-
grams.[47] Orbital interaction diagrams were prepared by using the
Gauss-view interface.[48]
Engl. 1969, 8, 604–606; Angew. Chem. 1969, 81, 621; c) H. Her-
mann, R. Huisgen, H. Mader, J. Am. Chem. Soc. 1971, 93,
1779–1781; d) R. Huisgen, H. Mader, J. Am. Chem. Soc. 1971,
93, 1777–1779.
a) C. Nájera, J. M. Sansano, Angew. Chem. Int. Ed. 2005, 44,
6272–6276; Angew. Chem. 2005, 117, 6428; b) G. Pandey, P.
Banerjee, S. R. Gadre, Chem. Rev. 2006, 106, 4484–4517; c) H.
Pellissier, Tetrahedron 2007, 63, 3235–3285; d) L. M. Stanley,
M. P. Sibi, Chem. Rev. 2008, 108, 2887–2902; e) C. Nájera,
J. M. Sansano, Monatsh. Chem. 2011, 142, 659–680; f) J. Adrio,
J. C. Carretero, Chem. Commun. 2011, 47, 6784–6794; g) A. L.
Cardoso, T. M. V. D. Pinho e Melo, Eur. J. Org. Chem. 2012,
6479–6501; h) J. Adrio, J. C. Carretero, Chem. Commun. 2014,
50, 12434–12446.
[10]
[11]
a) R. Narayan, M. Potowski, Z.-J. Jia, A. P. Antonchick, Acc.
Chem. Res. 2014, 47, 1296–1310; b) C. Nájera, J. M. Sansano,
Org. Biomol. Chem. 2009, 7, 4567–4581; c) E. San Sebastián,
T. Zimmerman, A. Zubía, Y. Vara, E. Martín, F. Sirockin, A.
Dejaegere, R. H. Stote, X. López, D. Pantoja-Uceda, M.
Valcárcel, L. Mendoza, F. Vidal-Vanaclocha, F. P. Cossío, F. J.
Blanco, J. Med. Chem. 2013, 56, 735–747; d) A. Zubía, L. Men-
doza, S. Vivanco, E. Aldaba, T. Carrascal, B. Lecea, A. Arrieta,
T. Zimmerman, F. Vidal-Vanaclocha, F. Cossío, Angew. Chem.
Int. Ed. 2005, 44, 2903–2907; Angew. Chem. 2005, 117, 2963;
e) A. Zubía, S. Ropero, D. Otaegui, E. Ballestar, M. F. Fraga,
M. Boix-Cornet, M. Berdasco, A. Martínez, L. Coll-Mulet, J.
Gil, F. P. Cossío, M. Esteller, Oncogene 2009, 28, 1477–1484.
a) A. Mateo-Alonso, C. Sooambar, M. Prato, Org. Biomol.
Chem. 2006, 4, 1629–1637; b) M. Quintana, M. Grzelczak, M.
Prato, Phys. Status Solidi B 2010, 247, 2645–2648; c) M. Quin-
tana, E. Vázquez, M. Prato, Acc. Chem. Res. 2013, 46, 138–
148; d) E. E. Maroto, A. de Cózar, S. Filippone, A. Martín-
Domenech, M. Suárez, F. P. Cossío, N. Martín, Angew. Chem.
Int. Ed. 2011, 50, 6060–6064; Angew. Chem. 2011, 123, 6184;
e) E. E. Maroto, S. Filippone, M. Suárez, R. Martínez-Álvarez,
A. de Cózar, F. P. Cossío, N. Martín, J. Am. Chem. Soc. 2014,
136, 705–712.
For the application of this methodology in very complex skel-
etons, see for example: a) R. Grigg, L. M. Duffy, M. J. Dorrity,
J. F. Malone, S. Rajviroongit, M. Thornton-Pett, Tetrahedron
1990, 46, 2213–2230; b) L. E. Overman, J. E. Tellew, J. Org.
Chem. 1996, 61, 8338–8340.
Other methods for the generation of azomethine ylides have
been employed, see: a) S. Kanemasa, K. Sakamoto, O. Tsuje,
Bull. Chem. Soc. Jpn. 1989, 62, 1960–1968; b) B. S. Orlek, P. G.
Sammes, D. J. Weller, J. Chem. Soc., Chem. Commun. 1993,
1412–1413.
Acknowledgments
Financial support was provided by the Brasilian Universiade Fed-
eral do Rio de Janeiro (UFRJ), the Fundação de Amparo à Pes-
quisa do Estado do Rio de Janeiro (FAPERJ) and the Coord-
enação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES),
by the Spanish Ministerio de Ciencia e Innovación (MICINN)
(projects CTQ2010-20387, Consolider Ingenio 2010, CSD2007-
00006), the Spanish Ministerio de Economía y Competitividad
(MINECO) (projects CTQ2013-43446-P, CTQ2014-51912-REDC,
and CTQ2013-45415-P), the Fondos Europeos para el Desarrollo
Regional (FEDER), the Generalitat Valenciana (PROMETEO
2009/039 and PROMETEOII/2014/017), the Basque Government
(GV/EJ, grant IT-324-07), and the Universities of Alicante and of
the Basque Country (UPV/EHU) (UFI11/22 QOSYC). The au-
thors thank the SGI/IZO-SGIker UPV/EHU and the DIPC for
generous allocation of computational and analytical resources.
Technical and human support provided by SGIker (UPV/EHU,
MINECO, GV/EJ, ESF) is gratefully acknowledged.
[12]
[1] This skeleton was first found in naturally occurring martinel-
line or martinellic acid alkaloid derivatives, which are bradiki-
nin receptor antagonists, see: C. J. Lovely, V. Badarinarayana,
Curr. Org. Chem. 2008, 12, 1431–1453.
[2] This arrangement is present in Sceletium alkaloids A4, see:
P. N. Confalone, E. M. Huie, J. Am. Chem. Soc. 1984, 106,
7175–7178.
[3] C. E. Augelli-Szafran, C. J. Blankley, J. C. Jaen, D. W. More-
land, C. B. Nelson, J. R. Penvose-Yi, R. D. Schwarz, A. J.
Thomas, J. Med. Chem. 1999, 42, 356–363.
[4] N. Arumugam, R. Raghunathan, A. I. Almansour, U. Karama,
Bioorg. Med. Chem. Lett. 2012, 22, 1375–1379.
[5] N. J. Parmar, B. R. Pansuriya, H. A. Barad, R. Kant, V. K.
Gupta, Bioorg. Med. Chem. Lett. 2012, 22, 4075–4079.
[6] C. D. Buarque, G. C. G. Militão, D. J. B. Lima, L. V. Costa-
Lotufo, C. Pessoa, M. Odorico de Moraes, E. Ferreira Cunha-
Junior, E. C. Torres-Santos, C. D. Netto, P. R. R. Costa, Bio-
org. Med. Chem. 2011, 19, 6885–6891.
[7] During the preparation of the manuscript, compounds 5 were
found to be promising inhibitors of TNF-α expression in ma-
crophages (unpublished results).
[8] a) Synthetic Applications of 1,3-Dipolar Cycloaddition Chemis-
try Towards Heterocycles and Natural Products (Eds.: A.
Padwa, W. H. Pearson), John Wiley & Sons, New Jersey, 2003;
b) C. Nájera, J. M. Sansano, Curr. Org. Chem. 2003, 7, 1105–
1150; c) W. Eberbach, Sci. Synth. 2004, 11, 441–498; d) I.
Coldham, R. Hufton, Chem. Rev. 2005, 105, 2765–2810; e) V.
Nair, T. D. Suja, Tetrahedron 2007, 63, 12247–12275; f) A.
Padwa, S. K. Bur, Tetrahedron 2007, 63, 5341–5378; g) S. Kane-
masa, Heterocycles 2010, 82, 87–200; h) W. Zhang, Chem. Lett.
2013, 42, 676–681.
[13]
[14]
[15]
[16]
Y. D. Gong, S. Najdi, M. M. Olmstead, M. J. Kurth, J. Org.
Chem. 1998, 63, 3081–3086.
Compounds 11 were also prepared by using a thermal arrange-
ment sequence, see: A. F. Khlebnikov, M. S. Novikov, R. R.
Kostikov, J. Kopf, Russ. J. Org. Chem. 2005, 41, 1367–1374.
Enantioselective [3+2] cyclization from 8 was also achieved
when a chiral PHOX ligand or a chiral phosphoric acid were
used, see: a) R. Stohler, F. Wahl, A. Pfaltz, Synthesis 2005,
1431–1436; b) N. Li, J. Song, X.-F. Tu, B. Liu, X.-H. Chen, L.-
Z. Gong, Org. Biomol. Chem. 2010, 8, 2016–2019.
a) R. Grigg, M. W. Jordan, J. F. Malone, Tetrahedron Lett.
1979, 20, 3877–3878; b) P. A. Armstrong, R. Grigg, M. W. Jor-
dan, J. F. Malone, Tetrahedron 1985, 41, 3547–3558; c) D. A.
Barr, R. Grigg, M. Q. N. Gunaratne, J. Kemp, P. McMeekin,
V. Sridharan, Tetrahedron 1988, 44, 557–570.
[17]
[18]
[19]
[20]
N. Arumugan, R. Raghunathan, A. I. Almansour, U. Karama,
Bioorg. Med. Chem. Lett. 2012, 22, 1375–1379.
1
3
5
2
2
4
Compound 11 (R , R , R = H, R = CO Me, R = Et, X =
O), was prepared by using the imine route in 38% yield and
5:1 dr from the corresponding starter 8 (see Armstrong et
al.[18b] and Barr et al.[18c]).
[9] a) R. Huisgen, W. Scheer, H. Mader, Angew. Chem. Int. Ed.
Engl. 1969, 8, 602–604; Angew. Chem. 1969, 81, 619; b) R. Hu-
isgen, W. Scheer, H. Mader, E. Brunn, Angew. Chem. Int. Ed.
[21]
Iminium salts 10 were allowed to react under thermal condi-
tions in a solvent-free process to yield products 11. N. J. Par-
Eur. J. Org. Chem. 2015, 4689–4698
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4697